Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Aurran-Schleinitz

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
British Journal of Haematology|August 25, 1999
Early progenitor cells from human mobilized peripheral blood express low levels of the flt3 receptor, but exhibit various biological responses to flt3-LT Aurran-Schleinitz, A M Imbert, L Humeau, et al.
Transplantation|February 15, 1996
Bone marrow and blood cells as alternative sources of hematopoietic progenitors after failure of a first collection. A single institution retrospective studyT Aurran-Schleinitz, C Chabannon, C Faucher, et al.
Leukemia|September 14, 1999
SHC and SHIP phosphorylation and interaction in response to activation of the FLT3 receptorS Marchetto, E Fournier, N Beslu, et al.
British Journal of Haematology|July 10, 2001
True histiocytic lymphoma following B-acute lymphoblastic leukaemia: case report with evidence for a common clonal origin in both neoplasmsR Bouabdallah, P Abéna, B Chetaille, et al.
La Revue De Medecine Interne|March 25, 2008
[Chronic lymphocytic leukaemia: current management]T Aurran-Schleinitz, C Arnoulet, V Ivanov, et al.
Blood Cancer Journal|March 12, 2016
Lenalidomide treatment and prognostic markers in relapsed or refractory chronic lymphocytic leukemia: data from the prospective, multicenter phase-II CLL-009 trialA Bühler, C-M Wendtner, T J Kipps, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
British Journal of Haematology|August 25, 1999
Early progenitor cells from human mobilized peripheral blood express low levels of the flt3 receptor, but exhibit various biological responses to flt3-LT Aurran-Schleinitz, A M Imbert, L Humeau, et al.
Transplantation|February 15, 1996
Bone marrow and blood cells as alternative sources of hematopoietic progenitors after failure of a first collection. A single institution retrospective studyT Aurran-Schleinitz, C Chabannon, C Faucher, et al.
Leukemia|September 14, 1999
SHC and SHIP phosphorylation and interaction in response to activation of the FLT3 receptorS Marchetto, E Fournier, N Beslu, et al.
British Journal of Haematology|July 10, 2001
True histiocytic lymphoma following B-acute lymphoblastic leukaemia: case report with evidence for a common clonal origin in both neoplasmsR Bouabdallah, P Abéna, B Chetaille, et al.
La Revue De Medecine Interne|March 25, 2008
[Chronic lymphocytic leukaemia: current management]T Aurran-Schleinitz, C Arnoulet, V Ivanov, et al.
Blood Cancer Journal|March 12, 2016
Lenalidomide treatment and prognostic markers in relapsed or refractory chronic lymphocytic leukemia: data from the prospective, multicenter phase-II CLL-009 trialA Bühler, C-M Wendtner, T J Kipps, et al.
Pageof 1